Research Paper Volume 10, Issue 11 pp 3371—3381
LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis
Figure 4. Interaction between CDKN2BAS and miR-153-5p regulates the expression of ARHGAP18. (A-B) The relative expression of miR-153-5p was detected by qRT-PCR after CDKN2BAS overexpression or knockdown; (C) The expression of ARHGAP18 was detected by qRT-PCR after miR-153-5p treatment; (D-F) Luciferase activity was detected in HCCLM3 cells. *P < 0.05, **P < 0.01, ***P < 0.001.